PDF herunterladen
Adipositas - Ursachen, Folgeerkrankungen, Therapie 2025; 19(02): 84-109
DOI: 10.1055/a-2552-3990
Leitlinie

Interdisziplinäre S3-Leitlinie zur „Prävention und Therapie der Adipositas“ der Deutschen Adipositas-Gesellschaft (DAG) – Überblick über die Empfehlungen zu den Themen „Stigmatisierung“, „Diagnostik“ und „Therapie“

Leitlinienkoordinator*in, stellvertretend für alle Arbeitsgruppenmitglieder:,
Martina de Zwaan
1   Klinik für Psychosomatik und Psychotherapie, Medizinische Hochschule Hannover, Hannover, Deutschland
,
Hans Hauner
1   Klinik für Psychosomatik und Psychotherapie, Medizinische Hochschule Hannover, Hannover, Deutschland
,
Verfasser des kondensierten Textes (Schriftleiter der Zeitschrift Adipositas):,
Christina Holzapfel
2   Institut für Ernährungsmedizin, School of Medicine and Health, Technische Universität München, München, Deutschland
3   Fachbereich Oecotrophologie, Hochschule Fulda, Fulda, Deutschland
,
Stefan Engeli
4   Abteilung für Klinische Pharmakologie, Institut für Pharmakologie am Center of Drug Absorption and Transport (C_DAT), Universitätsmedizin Greifswald, Greifswald, Deutschland
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Zusammenfassung

Dieser Artikel fasst einen wesentlichen Teil der Empfehlungen der im Herbst 2024 durch die Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) zertifizierte S3-Leitlinie zur „Prävention und Behandlung der Adipositas“ der Deutschen Adipositas-Gesellschaft (DAG) zusammen. Aus Platzgründen ausgeklammert werden die Kapitel „Definition und medizinische Einordnung von Übergewicht und Adipositas“, da die Leitlinie hier keine Empfehlungen gibt, und „Prävention“, da die Arbeitsgruppe eigene Publikationen zum Thema plant. Hier behandelt werden die Kapitel „Stigmatisierung“ (neu in der Leitlinie enthalten), „Diagnostik“ und „Therapie“, wobei hier auch neue Bereiche wie E-Health inkludiert sind. Hinsichtlich der Ernährungstherapie gibt es heute eine Vielfalt evidenzbasierter Ansätze, die eine stärker personalisierte Therapie erlauben. Die adjuvante Pharmakotherapie hat einen deutlich größeren Stellenwert als in der vorhergehenden Version der Leitlinie, da mit den Glucagon-like Peptide-1 (GLP-1)-basierten Wirkstoffen inzwischen sehr wirksame Ansätze nicht nur zur Gewichtsreduktion, sondern auch zur Besserung von Begleit- und Folgeerkrankungen vorliegen. Für das Kapitel „Adipositaschirurgie“ der Vorgängerversion der Leitlinie wurde wegen der begrenzten Resourcen auf eine Literaturrecherche verzichtet und stattdessen auf die „Leitlinie zur Adipositaschirurgie“ der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) aus dem Jahr 2018 verwiesen, deren baldige Aktualisierung beschlossen ist. Beide Leitlinien werden sich zukünftig ergänzen.

Abstract

This article summarizes most of the recommendations of the current German evidence-based guideline (certified by the Association of Scientific Medical Societies in Germany, AWMF) on the “Prevention and Treatment of Obesity”, which was put together by the German Association for the Study of Obesity. For the sake of space, we left out the chapter on “Definitions”, because no recommendations are stated there. A summary of the chapter on “Prevention“, will be separately published by the respective working group. We focus on the chapters on “Stigmatization” (new in this guideline version), “Diagnostics”, and “Therapy” which is supplemented by a discussion on E-Health approaches. Considering dietary therapy, many evidence-based approaches are available nowadays, allowing more personalized treatment considerations. Pharmacotherapy as an adjunct approach has become much more important since the last version of the guideline because Glucagon-like Peptide-1 (GLP-1)-based medicines not only improved the amount of weight loss but have also shown beneficial effects on several comorbidities of obesity. The last version of the guideline also included a chapter on “Obesity Surgery”. This chapter was left unchanged, because a seperate guideline from the German Society for General and Visceral Surgery on that issue exists and will be updated rather soon. In the future both guidelines will be used back-to-back.

Interdisciplinary S3 Guideline on “Prevention and Treatment of Obesity” by the German Association for the Study of Obesity (DAG) – Overview of the recommendations on the topics “Stigmatization,” “Diagnostics,” and “Therapy”

Schlüsselwörter

Übergewicht - Adipositas - evidenzbasierte Leitlinie - Stigmatisierung - Ernährungstherapie - Pharmakotherapie

Keywords

overweight - obesity - evidence-based guideline - stigmatization - dietary therapy - pharmacotherapy


Publikationsverlauf

Artikel online veröffentlicht:
13. Juni 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Deutsche Adipositas-Gesellschaft (DAG) e.V. S3-Leitlinie Adipositas – Prävention und Therapie. Version 5.0 Oktober 2024. Verfügbar unter https://register.awmf.org/de/leitlinien/detail/050-001
    PubMed
  • 2 Alimoradi Z. et al. Weight-related stigma and psychological distress: A systematic review and meta-analysis. Clin Nutr 2020; 39 p 2001-2013
    CrossrefPubMedSuche in Google Scholar
  • 3 Albano G. et al. Interpersonal difficulties in obesity: A systematic review and meta-analysis to inform a rejection sensitivity-based model. Neurosc Biobehav Rev 2019; 107: 846-861
    PubMedSuche in Google Scholar
  • 4 Emmer C, Bosnjak M, Mata J. The association between weight stigma and mental health: A meta-analysis. Obes Rev. 2019 21.
    PubMedSuche in Google Scholar
  • 5 Lee M, Ata RN, Brannick MT. Malleability of weight-biased attitudes and beliefs: A meta-analysis of weight bias reduction interventions. Body Image 2014; 11: 251-259
    PubMedSuche in Google Scholar
  • 6 Cameron AJ, Magliano DJ, Söderberg S. A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev 2012; 14: 86-94
    PubMedSuche in Google Scholar
  • 7 de Hollander EL. et al. The association between waist circumference and risk of mortality considering body mass index in 65- to 74-year-olds: a meta-analysis of 29 cohorts involving more than 58 000 elderly persons. Int J Epidemiol 2012; 41: 805-817
    PubMedSuche in Google Scholar
  • 8 Becroft L. et al. Validity of multi-frequency bioelectric impedance methods to measure body composition in obese patients: a systematic review. Int J Obes 2018; 43: 1497-1507
    PubMedSuche in Google Scholar
  • 9 Chang S-H. et al. A systematic review of body fat distribution and mortality in older people. Maturitas 2012; 72: 175-191
    PubMedSuche in Google Scholar
  • 10 Menotti A. et al. Indexes of Obesity and All-Causes Mortality in Italian Epidemiologic Data. Prev Med 1993; 22: 293-303
    PubMedSuche in Google Scholar
  • 11 Atlantis E. et al. Usefulness of the Edmonton Obesity Staging System for stratifying the presence and severity of weight-related health problems in clinical and community settings: A rapid review of observational studies. Obes Rev. 2020 21.
    PubMedSuche in Google Scholar
  • 12 Ejima K, Xavier NA, Mehta T. Comparing the Ability of Two Comprehensive Clinical Staging Systems to Predict Mortality: EOSS and CMDS. Obesity 2020; 28: 353-361
    PubMedSuche in Google Scholar
  • 13 Manasse SM. et al. Executive functioning in overweight individuals with and without loss-of-control eating. Eur Eat Disord Rev 2014; 22: 373-377
    PubMedSuche in Google Scholar
  • 14 Palavras MA. et al. The Efficacy of Psychological Therapies in Reducing Weight and Binge Eating in People with Bulimia Nervosa and Binge Eating Disorder Who Are Overweight or Obese-A Critical Synthesis and Meta-Analyses. Nutrients 2017; 9: 299
    PubMedSuche in Google Scholar
  • 15 Somerset SM, Graham L, Markwell K. Depression scores predict adherence in a dietary weight loss intervention trial. Clin Nutr 2011; 30: 593-598
    PubMedSuche in Google Scholar
  • 16 Lammert A. et al. Performance of the 1 mg dexamethasone suppression test in patients with severe obesity. Obesity (Silver Spring) 2016; 24: 850-855
    PubMedSuche in Google Scholar
  • 17 Yavuz DG. et al. Assessment of 1 mg Dexamethasone Suppression Test in Patients with Obesity Before Bariatric Surgery. Obes Surg 2020; 30: 4981-4985
    PubMedSuche in Google Scholar
  • 18 Assmann G, Cullen P, Schulte H. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation 2002; 105: 310-315
    PubMedSuche in Google Scholar
  • 19 Assmann G. et al. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study. Eur J Clin Invest 2007; 37: 925-932
    PubMedSuche in Google Scholar
  • 20 Conroy RM. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003
    CrossrefPubMedSuche in Google Scholar
  • 21 Zhao L. et al. Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis. Chin Med J 2020; 133: 982-993
    PubMedSuche in Google Scholar
  • 22 Institute for Evidence-Based Healthcare, BondUniversity. Evidence synthesis to support the development of guideline for cardiovascular disease risk, 2021: https://d35rj4ptypp2hd.cloudfront.net/pdf/7.-Report-1-Evidence-Synthesis-Report-Bond-University.pdf
    PubMed
  • 23 Parhofer KG, Laufs U. The Diagnosis and Treatment of Hypertriglyceridemia. Dtsch Arztebl Int 2019; 116: 825-832
    CrossrefPubMedSuche in Google Scholar
  • 24 DEGAM. AWMF S3-Leitlinie Hausärztliche Risikoberatung zur kardiovaskulären Prävention.
    PubMed
  • 25 Hemingway H. et al. Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS medicine 2010; 7: e1000286-e1000286
    PubMedSuche in Google Scholar
  • 26 Schwarzer R. et al. Prognostische Wertigkeit und klinische Effektivität des hochsensitiven C-reaktiven Proteins als Marker in der Primärprävention der koronaren Herzkrankheit. Z Evid Fortbild Qual Gesundhwes 2009; 103: 319-329
    PubMedSuche in Google Scholar
  • 27 Schnell-Inderst P. et al. Stellenwert des hochsensitiven C-reaktiven Proteins (hs-CRP) als Marker für Herzinfarktgefährdung. GMS Health Technol Assess 2009; 5: Doc06
    PubMedSuche in Google Scholar
  • 28 Si S. et al. Effectiveness of general practice-based health checks: a systematic review and meta-analysis. Br J Gen Pract 2014; 64: e47-e53
    PubMedSuche in Google Scholar
  • 29 Lee J. et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. Liver Int 2021; 41: 261-270
    CrossrefPubMedSuche in Google Scholar
  • 30 Wangler J, Jansky M. [Clarification of increased liver values in primary care – Findings from a series of studies from a general practitioner and specialist perspective]. Z Gastroenterol 2023; 61: 381-389
    Thieme ConnectPubMedSuche in Google Scholar
  • 31 Scottish Intercollegiate Guidelines Network (SIGN). Management of Obesity. A national clinical guideline. 2010 June 10, 2022]; Available from https://www.sign.ac.uk/assets/sign115.pdf
    PubMed
  • 32 Wu T. et al. Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev 2009; 10: 313-323
    PubMedSuche in Google Scholar
  • 33 Södlerlund A, Fischer A, Johansson T. Physical activity, diet and behaviour modification in the treatment of overweight and obese adults: a systematic review. Perspect Public Health 2009; 129: 132-142
    PubMedSuche in Google Scholar
  • 34 Witham MD, Avenell A. Interventions to achieve long-term weight loss in obese older people: a systematic review and meta-analysis. Age Ageing 2010; 39: 176-184
    PubMedSuche in Google Scholar
  • 35 Johns DJ. et al. Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta-analysis of direct comparisons. J Acad Nutr Diet 2014; 114: 1557-1568
    PubMedSuche in Google Scholar
  • 36 Ge L. et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ 2020; 369: m696
    CrossrefPubMedSuche in Google Scholar
  • 37 Singh N, Stewart RAH, Benatar JR. Intensity and duration of lifestyle interventions for long-term weight loss and association with mortality: a meta-analysis of randomised trials. BMJ open 2019; 9: e029966-e029966
    PubMedSuche in Google Scholar
  • 38 Hartmann-Boyce J. et al. Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis. Obes Rev 2014; 15: 920-932
    CrossrefPubMedSuche in Google Scholar
  • 39 Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ (Clinical research ed.) 2020; 370: m3095-m3095
    PubMedSuche in Google Scholar
  • 40 Astbury NM. et al. A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss. Obes Rev 2019; 20: 569-587
    CrossrefPubMedSuche in Google Scholar
  • 41 Harris L. et al. Intermittent fasting interventions for treatment of overweight and obesity in adults. JBI Database System Rev Implement Rep 2018; 16: 507-547
    CrossrefPubMedSuche in Google Scholar
  • 42 Roman YM. et al. Effects of intermittent versus continuous dieting on weight and body composition in obese and overweight people: a systematic review and meta-analysis of randomized controlled trials. Int J Obes 2018; 43: 2017-2027
    PubMedSuche in Google Scholar
  • 43 Noronha JC. et al. The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diab Care 2019; 42: 767-776
    PubMedSuche in Google Scholar
  • 44 Parretti HM. et al. Clinical effectiveness of very-low-energy diets in the management of weight loss: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2016; 17: 225-234
    PubMedSuche in Google Scholar
  • 45 Muscogiuri G. et al. European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis. Obes Facts 2021; 14: 222-245
    PubMedSuche in Google Scholar
  • 46 Donnelly JE. et al. Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults. Med Sci Sports Exerc 2009; 41: 459-471
    CrossrefPubMedSuche in Google Scholar
  • 47 Wewege M. et al. The effects of high-intensity interval training vs. moderate-intensity continuous training on body composition in overweight and obese adults: a systematic review and meta-analysis. Obes Rev 2017; 18: 635-646
    PubMedSuche in Google Scholar
  • 48 Anderson JW. et al. Effect of a behavioral/nutritional intervention program on weight loss in obese adults: a randomized controlled trial. Postgrad Med 2011; 123: 205-213
    PubMedSuche in Google Scholar
  • 49 Rodriguez-Hernandez H. et al. Adding cognitive behavioural treatment to either low-carbohydrate or low-fat diets: differential short-term effects. Br J Nutr 2009; 102: 1847-1853
    PubMedSuche in Google Scholar
  • 50 Acharya SD. et al. Using a personal digital assistant for self-monitoring influences diet quality in comparison to a standard paper record among overweight/obese adults. J Am Diet Assoc 2011; 111: 583-588
    PubMedSuche in Google Scholar
  • 51 Burke LE. et al. The effect of electronic self-monitoring on weight loss and dietary intake: a randomized behavioral weight loss trial. Obesity (Silver Spring) 2011; 19: 338-344
    PubMedSuche in Google Scholar
  • 52 Wing RR. et al. Improving weight loss outcomes of community interventions by incorporating behavioral strategies. Am J Public Health 2010; 100: 2513-2519
    PubMedSuche in Google Scholar
  • 53 Burke LE, Wang J, Sevick MA. Self-monitoring in weight loss: a systematic review of the literature. J Am Diet Assoc 2011; 111: 92-102
    PubMedSuche in Google Scholar
  • 54 Teufel M. et al. Psychotherapie und Adipositas. Der Nervenarzt 2011; 82: 1133-1139
    PubMedSuche in Google Scholar
  • 55 Khera R. et al. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA 2016; 315: 2424-2434
    CrossrefPubMedSuche in Google Scholar
  • 56 Khera R. et al. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis. Gastroenterology 2018; 154: 1309-1319.e7
    CrossrefPubMedSuche in Google Scholar
  • 57 Siebenhofer A. et al. Long-term effects of weight-reducing drugs in people with hypertension. Cochrane Database Syst Rev 2021; 1: Cd007654
    PubMedSuche in Google Scholar
  • 58 Singh AK, Singh R. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs. Expert Rev Clin Pharmacol 2020; 13: 53-64
    PubMedSuche in Google Scholar
  • 59 Rubino D. et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA 2021; 325: 1414-1425
    CrossrefPubMedSuche in Google Scholar
  • 60 Jastreboff AM. et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022; 387: 205-216
    CrossrefPubMedSuche in Google Scholar
  • 61 Yen HY, Chiu HL. The effectiveness of wearable technologies as physical activity interventions in weight control: A systematic review and meta-analysis of randomized controlled trials. Obes Rev 2019; 20: 1485-1493
    PubMedSuche in Google Scholar
  • 62 Cavero-Redondo I. et al. Effect of Behavioral Weight Management Interventions Using Lifestyle mHealth Self-Monitoring on Weight Loss: A Systematic Review and Meta-Analysis. Nutrients 2020; 12
    PubMedSuche in Google Scholar
  • 63 Beleigoli A. et al. Personalized Web-Based Weight Loss Behavior Change Program With and Without Dietitian Online Coaching for Adults With Overweight and Obesity: Randomized Controlled Trial. J Med Internet Res 2020; 22: e17494
    PubMedSuche in Google Scholar
  • 64 Huang JW, Lin YY, Wu NY. The effectiveness of telemedicine on body mass index: A systematic review and meta-analysis. J Telemed Telecare 2019; 25: 389-401
    PubMedSuche in Google Scholar
  • 65 Skinner R. et al. A systematic review with meta-analyses of text message-delivered behaviour change interventions for weight loss and weight loss maintenance. Obes Rev 2020; 21: e12999
    PubMedSuche in Google Scholar
  • 66 Villinger K. et al. The effectiveness of app-based mobile interventions on nutrition behaviours and nutrition-related health outcomes: A systematic review and meta-analysis. Obes Rev 2019; 20: 1465-1484
    CrossrefPubMedSuche in Google Scholar
  • 67 Ross Middleton KM, Patidar SM, Perri MG. The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 2012; 13: 509-517
    CrossrefPubMedSuche in Google Scholar
  • 68 Dombrowski SU. et al. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials. BMJ (Clinical research ed.) 2014; 348: g2646-g2646
    PubMedSuche in Google Scholar
  • 69 Peirson L. et al. Strategies for weight maintenance in adult populations treated for overweight and obesity: a systematic review and meta-analysis. CMAJ open 2015; 3: E47-E54
    PubMedSuche in Google Scholar
  • 70 Varkevisser RDM. et al. Determinants of weight loss maintenance: a systematic review. Obes Rev 2019; 20: 171-211
    CrossrefPubMedSuche in Google Scholar